Azitra Inc stock is traded at $0.5168, with a volume of 54,083. It is down -2.75% in the last 24 hours and down -27.72% over the past month. Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
Previous Close:
$0.5314
Open:
$0.5411
24h Volume:
54,083
Relative Volume:
0.47
Market Cap:
$3.13M
Revenue:
$7,500
Net Income/Loss:
-$10.96M
P/E Ratio:
-
EPS:
-$2.29
Net Cash Flow:
-$11.41M
1W Performance:
-15.06%
1M Performance:
-27.72%
6M Performance:
-73.77%
1Y Performance:
-83.80%
1-Day Range:
$0.5086$0.5523
1-Week Range:
$0.5086$0.6524
52-Week Range:
$0.5086$4.30
Azitra Inc Stock (AZTR) Company Profile
Name
Azitra IncSector
HealthcareIndustry
BiotechnologyPhone
203 646 6446Address
21 Business Park Drive, Branford, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS